SAB Biotherapeutics, Inc 10-K for FY2023
SAB Biotherapeutics, Inc. (SABS)
10-K
2024-03-29
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 10-K
SAB Biotherapeutics, Inc filed this 10-K on March 29, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.24M
- down 90.6% from $23.9M a year earlier
- Net loss
- $42.19M
- compared with a net loss of $18.74M a year earlier
- Diluted EPS
- -$7.64
- compared with -$4.31 a year earlier